| Financial Year |
March 31 2023 |
| Monetary Funds |
3,926,950,537.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
557,318,385.15 |
| Accounts Receivable |
2,203,335,198.97 |
| Advances to Suppliers |
110,117,124.72 |
| Other Receivables |
209,102,103.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,370,524,466.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,971,435.36 |
| Total Current Assets |
8,403,794,273.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,301,904,944.22 |
| Under-construction Projects |
391,857,875.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
694,584,835.21 |
| R&D expenses |
145,439,767.53 |
| Goodwill |
26,118,604.81 |
| Long-Term Deferred and Prepaid Expenses |
641,985.77 |
| Deferred Income Tax Assets |
103,723,263.26 |
| Other Non-Current Assets |
60,420,618.05 |
| Sub-Total of Non-Current Assets |
5,782,331,841.57 |
| Total Assets |
14,186,126,115.14 |
| Short-Term Loans |
2,130,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,463,350,499.02 |
| Accounts Payable |
1,879,417,284.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,438,093.17 |
| Taxes Payable |
146,022,094.69 |
| Interest Payable |
-- |
| Dividend Payable |
1,597,979.18 |
| Other payables |
1,781,743,871.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
97,781,843.07 |
| Other Current Liabilities |
14,042,203.62 |
| Sub-Total of Current Liabilities |
8,671,322,954.07 |
| Long-term Loans |
238,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,287,981.13 |
| Other Non-Current Liabilities |
238,000,000.00 |
| Sub-Total of Non-Current Liabilities |
686,341,981.88 |
| Total Liabilities |
9,357,664,935.95 |
| Paid-In Capital(Or Share Stock) |
1,434,316,265.00 |
| Capital Surplus |
2,416,361,969.87 |
| Surplus Reserve |
172,911,034.42 |
| LESS:Treasury Stock |
234,779,188.00 |
| Undistributed Profits |
875,226,134.55 |
| Minority Stockholder's Interest |
157,178,718.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,671,282,461.18 |
| Owner's Equity（Stockholder's Equity） |
4,828,461,179.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,186,126,115.14 |
